Company Introduced New Leadership and Three New Products at Event, Kannaway Pure CBD Liquid, Kannaway Pure CBD Capsules, and Kannaway Premium Hemp Oil Capsules. 

Medical Marijuana, Inc. (OTC: MJNA) announced today that its portfolio company Kannaway, LLC, the first hemp lifestyle direct selling company to offer cannabidiol (CBD) hemp botanical products, launched a refresh of its world-renowned brand at its ‘Genesis: People, Purpose, Passion’ event in San Diego this November.  

The two-day ‘Genesis’ event included award-winning trainings sessions, including Kannaway leaders discussing best practices for building a better business. Kannaway also introduced new leadership at the event, including direct sales expert Randy Schroeder, who brings his “25 years” training module to the company. In addition, a Kannaway stock incentive plan was announced for brand ambassadors, plus an incentive trip on a seven-day cruise to Cabo San Lucas, Mexico. Kannaway also celebrated two new brand ambassadors that achieved “platinum” level.  As a part of Kannaway’s on-going social responsibility initiatives, Brand Ambassadors made donations to Kannaway’s new charitable benefactor, E.C.H.O.

“This event marks the ‘Genesis’ of a new Kannaway,” stated Kannaway CEO Blake Schroeder. “We were proud to launch our new message and brand, as well as 3 new high quality products.  Our Brand Ambassadors are very excited about our new Brand Ambassador stock incentive program.  As a company we were most proud to launch E.C.H.O, which stands for Education, Collaboration, and Hope, and to have made, along with our Brand Ambassadors, our very first contribution to that endeavor."  

The Company also announced at the event the addition of three new products to its line of CBD hemp oil lifestyle products. Kannaway Pure CBD Liquid is the Company’s new herbal-extract free, naturally-high CBD hemp oil product that invigorates the system while promoting overall homeostasis. Kannaway Pure CBD Capsules are a refined, CBD-only supplement, and make including a CBD supplement to a diet easy. Premium Hemp Oil Capsules join the Kannaway Premium Hemp product line offering a full-spectrum cannabinoid blend though a capsule delivery method.

Kannaway has also redesigned its website to reflect the Company’s new branding. The website includes a new video series that tells the story of Kannaway and educates on the endocannabinoid system and CBD. 

For more information on Kannaway, click here to visit the Company website.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 888-829- 0070

Corporate Business Contact:

Nicholas R. Massalas

Director of Business Development

Medical Marijuana, Inc.

OTC Symbol: MJNA

Toll Free: 888-OTC- MJNA (888-682- 6562)

Investor Relations Contact:

EquiNet, LLC

Toll Free: (877) 964.6463

Office/Direct: (858) 264-6500






About Kannaway, LLC

Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.



These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.



Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil